In glaucoma patients, low blood pressure is accompanied by vascular dysregulation

青光眼患者常伴有低血压和血管功能紊乱。

阅读:1

Abstract

BACKGROUND: There are many risk factors contributing to glaucomatous optic neuropathy. Beside increased intraocular pressure, vascular factors play a prominent role, particularly low blood pressure (BP), and vascular dysregulation. Both of them are essential components of the Flammer syndrome. The aim of this retrospective study was to evaluate whether in glaucoma patients there is a relationship between vascular dysregulation and the BP. METHODS: Medical records of 57 unselected glaucoma patients were retrospectively studied. RESULTS: Based on the outcome of the capillaroscopy, patients were divided in a group of patients with vascular dysregulation, also called long-stoppers (flow cessation for 13 s or more), and a group of patients with normal vascular regulation, also called short-stoppers (flow cessation for 12 s or less). BP was significantly lower in the group of long-stoppers than in the group of short-stoppers. This applies for both systolic (p = 0.028) and diastolic BP (p = 0.036). The regression analysis revealed also a significant inverse relationship between the duration of blood flow cessation and the systolic (p = 0.025) and diastolic BP (p = 0.016). After adjustment for age, gender, use of antihypertensive therapy, and excluding patients taking calcium channel blockers, the relationship was still significant for systolic (p = 0.025) and diastolic BP (p = 0.003). CONCLUSIONS: In glaucoma patients, vascular dysregulation (as defined by response in the nailfold capillaroscopy to a cold provocation) and low BP are statistically related. This is in line with the observation that Flammer syndrome subjects have both primary vascular dysregulation and low BP and that Flammer syndrome is a risk factor for glaucomatous optic neuropathy, at least in normal tension glaucoma patients. The detection of vascular factors in glaucoma patients may lead to a more efficient treatment, better tailored to the individual patient.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。